Difference between revisions of "Team:Montpellier/WetLab Peptides"

 
(23 intermediate revisions by 2 users not shown)
Line 25: Line 25:
 
<h3>General design</h3>
 
<h3>General design</h3>
  
<p>Each of our constructions contained RpsU promoter <a class="lien" href="#references">[1]</a> which is a Lactobacillus jensenii strong promoter.  This RpsU sequence also contains the putative sequence for the RBS.
+
<p>Each of our constructions contained RpsU promoter <a class="lien" href="#references">[1]</a> which is a <i>Lactobacillus jensenii</i> strong promoter.  This RpsU sequence also contains the putative sequence for the RBS.
The same scaffold is used for all of our designs to facilitate their constructions (ref Guiziou et al., NAR 2016). We added spacers to all of our constructions to unable easier use of the sequence and separation of the different genes of the sequences. The spacers are of 40bp to facilitate cloning by Gibson assembly. We used two Terminators to our sequences :BBa_B0014 & BBa_B0015 to ensure the stopping of the transcription.  
+
The same scaffold is used for all of our designs to facilitate their constructions <a class="lien" href="#references">[2]</a>. We added spacers to all of our constructions to unable easier use of the sequence and separation of the different genes of the sequences. The spacers are of 40bp to facilitate cloning by Gibson assembly. We used two Terminators to our sequences :BBa_B0014 & BBa_B0015 to ensure the stopping of the transcription.  
Our constructions were assembled in the Plem415 vector by Gibson Assembly method. Plem 415 is a plasmid that works in Lactobacilli species but it’s not specific to <i>L. jensenii</i> <a class="lien" href="#references">[2]</a>.
+
Our constructions were assembled in the pLEM415 vector by Gibson Assembly method. pLEM415 is a plasmid that works in Lactobacilli species but it’s not specific to <i>L. jensenii</i> <a class="lien" href="#references">[3]</a>.
  
 
<p>For the next design schemes the general legend is presented on figure 1: </p>
 
<p>For the next design schemes the general legend is presented on figure 1: </p>
  
 
<center><img class="legend" src="https://static.igem.org/mediawiki/2018/7/7f/T--Montpellier--design_legende3_montpellier.png"></center><br/>
 
<center><img class="legend" src="https://static.igem.org/mediawiki/2018/7/7f/T--Montpellier--design_legende3_montpellier.png"></center><br/>
<figcaption> <span class="underline">Figure 1:</span>Figure 1 : Explanations for the design schemes</figcaption>
+
<figcaption> <span class="underline">Figure 1:</span> Explanations for the design schemes</figcaption>
  
 
<h3>LL-37</h3>
 
<h3>LL-37</h3>
Line 62: Line 62:
 
<h3>Nisin</h3>
 
<h3>Nisin</h3>
  
<p> The nisin pathway is complex and really difficult to design in <i> E.coli </i> or Gram positive. Indeed, we need to encode  12 genes to produce and secrete nisin. <strong>Kong & Al</strong> sent us the plasmid pWK6 (20 kB) to insert into <i> E. coli</i> [3] . </p>
+
<p> The nisin pathway is complex and really difficult to design in <i> E.coli </i> or Gram positive. Indeed, we need to encode  12 genes to produce and secrete nisin. <strong>Kong & Al</strong> sent us the plasmid pWK6 (20 kB) to insert into <i> E. coli</i> <a class="lien" href="#references">[4]</a> <!--(Figure 7). </p>
  
<img src="https://static.igem.org/mediawiki/2018/c/cb/T--Montpellier--pwk6_wetlab_peptides_mtp.png">
+
 
 +
<p><figcaption><span class="underline">Figure 7</span>: The pWK6 plasmid</figcaption></p> -->
 +
 
 +
<h2>Experiments</h2>
 +
 
 +
<p>We had issues for synthesizing the different sequences, due to their complexity and length the two companies that we contacted were not able to synthetize them even in multiple fragments. Consequently, Lacticin and Subtilosin were not used for the rest of the project. Only the sequence for LL-37 was used.</p>
 +
 
 +
<p>The part coding LL-37 peptide was successfully cloned in <i>E. coli</i>.</p>
 +
<p>We checked the insertion of the vector containing this part by PCR and electrophoresis (figure 7).</p>
 +
<img src="https://static.igem.org/mediawiki/2018/b/b3/T--Montpellier--peptides_wetlab_mtp.png">
 +
<p><figcaption><span class="underline">Figure 7</span>: Gel after electrophoresis of colony PCR of pLEM415 plasmid with different inserts. For each insert two colonies were picked.</figcaption></p>
 +
 
 +
<p>For LL-37 the second colony (15) contained the insert. The sequencing proved that the sequence was correct.<p>
 +
 
 +
<p>This peptide was too small to do SDS-Page to detect its production. We decided to use our sperm motility assay as a way to detect its activity. The experimental designs can be found in the analysis of <a class="lien" href="https://2018.igem.org/Team:Montpellier/Demonstrate">sperm motility section</a>.
 +
Unfortunately, we were not able to do the experiments for LL-37 activity assay after finishing to test and validate our experimental protocol. </p>
 +
 
 +
<h2>Summary</h2>
 +
 
 +
 
 +
 
 +
<table>
 +
 +
  <tr>
 +
      <th></th>
 +
      <th>Designed</th>
 +
      <th>cloned</th>
 +
      <th>Characterized</th>
 +
  </tr>
 +
  <tr>
 +
<td>LL37</td>
 +
<td>YES</td>
 +
      <td>YES</td>
 +
      <td>NO</td>
 +
  </tr>
 +
  <tr>
 +
<td>Subtilosin</td>
 +
<td>YES</td>
 +
      <td>NO</td>
 +
      <td>NO</td>
 +
  </tr>
 +
  <tr>
 +
<td>Lacticin</td>
 +
<td>YES</td>
 +
      <td>NO</td>
 +
      <td>NO</td>
 +
  </tr>
 +
  <tr>
 +
<td>Nisin</td>
 +
<td>NO</td>
 +
      <td>YES</td>
 +
      <td>NO</td>
 +
  </tr>
 +
</table>
 +
<figcaption> <span class="underline">Figure 8:</span> Experiments that we carried on</figcaption>  
  
 
</section>
 
</section>
Line 76: Line 130:
 
       <tr>
 
       <tr>
 
       <td class="references_left">[1]</td>
 
       <td class="references_left">[1]</td>
       <td class="references_right">Xiaowen Liu, et al,. 2006. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. <i>Antimicrobial agents and chemotherapy</i> 50(10), 3250-3259.</td>
+
       <td class="references_right">Liu, X., Lagenaur, L. A., Simpson, D. A., Essenmacher, K. P., Frazier-Parker, C. L., Liu, Y., ... & Lee, P. P. (2006). Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. <i>Antimicrobial agents and chemotherapy, 50</i>(10), 3250-3259.</td>
 
     </tr>
 
     </tr>
 
       <tr>
 
       <tr>
 
       <td class="references_left">[2]</td>
 
       <td class="references_left">[2]</td>
       <td class="references_right">Bao, Sujin, et al.2013 "Distribution dynamics of recombinant Lactobacillus in the gastrointestinal tract of neonatal rats." PloS one 8.3 (2013): e60007.</td>
+
       <td class="references_right">Guiziou, et al., (2016). "A part toolbox to tune genetic expression in <i>Bacillus subtilis</i>" <i>Nucleic Acids</i> Res. 2016 Sep 6;44(15):7495-508. doi: 10.1093/nar/gkw624. Epub 2016 Jul 8..</td>
 +
    </tr>
 +
      <tr>
 +
      <td class="references_left">[3]</td>
 +
      <td class="references_right">Bao, S., Zhu, L., Zhuang, Q., Wang, L., Xu, P. X., Itoh, K., ... & Lin, J. (2013). Distribution dynamics of recombinant <i>Lactobacillus</i> in the gastrointestinal tract of neonatal rats. <i>PloS one, 8</i>(3), e60007.</td>
 +
    </tr>
 +
      <tr>
 +
      <td class="references_left">[4]</td>
 +
      <td class="references_right">Wentao Kong, David R. Meldgin, James J. Collins and Ting Lu (2018). Designing microbial consortia with defined social interactions <i>Nat Chem Biol</i>821-829. doi:10.1038/s41589-018-0091-7</td>
 
     </tr>
 
     </tr>
 
   </table>
 
   </table>

Latest revision as of 16:50, 17 October 2018

Design


General design

Each of our constructions contained RpsU promoter [1] which is a Lactobacillus jensenii strong promoter. This RpsU sequence also contains the putative sequence for the RBS. The same scaffold is used for all of our designs to facilitate their constructions [2]. We added spacers to all of our constructions to unable easier use of the sequence and separation of the different genes of the sequences. The spacers are of 40bp to facilitate cloning by Gibson assembly. We used two Terminators to our sequences :BBa_B0014 & BBa_B0015 to ensure the stopping of the transcription. Our constructions were assembled in the pLEM415 vector by Gibson Assembly method. pLEM415 is a plasmid that works in Lactobacilli species but it’s not specific to L. jensenii [3].

For the next design schemes the general legend is presented on figure 1:


Figure 1: Explanations for the design schemes

LL-37

For the LL-37 sequence we used the RpsU promoter and the sequence coding the LL-37 peptide.

Figure 2: Design of the sequence coding the LL-37 protein with the RpsU promoter.

Figure 3: Design of the sequence coding the LL-37 protein with the pHyperSpank promoter.

SubtilosinA


Figure 4: Design of the sequence coding the Subtilosin protein with the RpsU promoter.


Figure 5: Design of the sequence coding the Iron Sulfur Cluster with the RpsU promoter.

Lacticin 3147

This circuit was made from 2 native genes of Lactococcus lactis ltA1 and ltnA that express Lacticin peptide. Also, the design contains Lacticin-post-transcriptional regulator ltM1 and M2. A promoter orthogonal was used : ptsH and differents spacer taken from igem_parts.

Figure 6: Design of the sequence coding the Lacticin 3147

Nisin

The nisin pathway is complex and really difficult to design in E.coli or Gram positive. Indeed, we need to encode 12 genes to produce and secrete nisin. Kong & Al sent us the plasmid pWK6 (20 kB) to insert into E. coli [4]

Experiments

We had issues for synthesizing the different sequences, due to their complexity and length the two companies that we contacted were not able to synthetize them even in multiple fragments. Consequently, Lacticin and Subtilosin were not used for the rest of the project. Only the sequence for LL-37 was used.

The part coding LL-37 peptide was successfully cloned in E. coli.

We checked the insertion of the vector containing this part by PCR and electrophoresis (figure 7).

Figure 7: Gel after electrophoresis of colony PCR of pLEM415 plasmid with different inserts. For each insert two colonies were picked.

For LL-37 the second colony (15) contained the insert. The sequencing proved that the sequence was correct.

This peptide was too small to do SDS-Page to detect its production. We decided to use our sperm motility assay as a way to detect its activity. The experimental designs can be found in the analysis of sperm motility section. Unfortunately, we were not able to do the experiments for LL-37 activity assay after finishing to test and validate our experimental protocol.

Summary

Designed cloned Characterized
LL37 YES YES NO
Subtilosin YES NO NO
Lacticin YES NO NO
Nisin NO YES NO
Figure 8: Experiments that we carried on
References
[1] Liu, X., Lagenaur, L. A., Simpson, D. A., Essenmacher, K. P., Frazier-Parker, C. L., Liu, Y., ... & Lee, P. P. (2006). Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrobial agents and chemotherapy, 50(10), 3250-3259.
[2] Guiziou, et al., (2016). "A part toolbox to tune genetic expression in Bacillus subtilis" Nucleic Acids Res. 2016 Sep 6;44(15):7495-508. doi: 10.1093/nar/gkw624. Epub 2016 Jul 8..
[3] Bao, S., Zhu, L., Zhuang, Q., Wang, L., Xu, P. X., Itoh, K., ... & Lin, J. (2013). Distribution dynamics of recombinant Lactobacillus in the gastrointestinal tract of neonatal rats. PloS one, 8(3), e60007.
[4] Wentao Kong, David R. Meldgin, James J. Collins and Ting Lu (2018). Designing microbial consortia with defined social interactions Nat Chem Biol821-829. doi:10.1038/s41589-018-0091-7